TOPOLOGY: A phase II study to evaluate the efficacy and toxicities of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer

被引：0
|
作者：
Cabel, Luc
Loirat, Delphine
Babau, Jerome Martin
Bello, Diana
Pierga, Jean-Yves
Lerebours, Florence
Ezzili, Cyrine
Berger, Frederique
Bidard, Francois Clement
机构：
[1] Inst Curie, Paris, France
[2] Inst Curie, St Cloud, France
[3] Inst Curie, Med Oncol Dept & D3i, Paris, France
[4] Hop Prive Cotes Armor, Plerin, France
[5] Inst Curie, Med Oncol Dept, St Cloud, France
[6] Inst Curie Paris, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS1142
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer
    Chumsri, Saranya
    Larson, Joseph
    Adams, Daniel
    Tenner, Kathleen
    Tang, Cha-Mei
    Weidner, Morgan
    Arnold, Amanda
    Haley, Dana
    Advani, Pooja
    Sideras, Kostandinos
    Moreno-Aspitia, Alvaro
    Perez, Edith
    Knutson, Keith
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer
    Chumsri, Saranya
    Larson, Joseph J.
    Tenner, Kathleen S.
    He, Jun
    Polley, Mei-Yin
    Weidner, Morgan T.
    Arnold, Amanda N.
    Haley, Dana
    Advani, Pooja
    Sideras, Kostandinos
    Moreno-Aspitia, Alvaro
    Perez, Edith A.
    Knutson, Keith L.
    CANCER RESEARCH, 2023, 83 (05)
  • [3] Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
    Tolaney, Sara M.
    Ziehr, David R.
    Guo, Hao
    Ng, Mei R.
    Barry, William T.
    Higgins, Michaela J.
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena V.
    Paweletz, Cloud P.
    Demeo, Michelle K.
    Ramaiya, Nikhil H.
    Overmoyer, Beth A.
    Jain, Rakesh K.
    Winer, Eric P.
    Duda, Dan G.
    ONCOLOGIST, 2017, 22 (01): : 25 - 32
  • [4] Phase I results of the phase I/II study of pembrolizumab in combination with binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer
    Chumsri, Saranya
    Polley, Mei-Yin
    Mathur, Pulkit
    Reis, Aline
    Tenner, Kathleen S.
    Weidner, Morgan
    Advani, Pooja
    Moreno-Aspitia, Alvaro
    Perez, Edith A.
    Knutson, Keith L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [5] A Phase II study of cabozantinib for metastatic triple-negative breast cancer (TNBC).
    Tolaney, Sara M.
    Ziehr, David R.
    Guo, Hao
    Barry, William Thomas
    Higgins, Michaela Jane
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena
    Paweletz, Cloud
    Demeo, Michelle
    Ramaiya, Nikhil H.
    Overmoyer, Beth
    Jain, Rakesh K.
    Duda, Dan G.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer
    Meng, Yanchun
    Jin, Juan
    Gong, Chengcheng
    Miao, Haitao
    Tao, Zhonghua
    Li, Ting
    Cao, Jun
    Wang, Leiping
    Wang, Biyun
    Zhang, Jian
    Hu, Xichun
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (11) : 11255 - 11264
  • [7] Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer
    Tolaney, Sara M.
    Tan, Sally
    Guo, Hao
    Barry, William
    Van Allen, Eliezer
    Wagle, Nikhil
    Brock, Jane
    Larrabee, Katherine
    Paweletz, Cloud
    Ivanova, Elena
    Janne, Pasi
    Overmoyer, Beth
    Wright, John J.
    Shapiro, Geoffrey I.
    Winer, Eric P.
    Krop, Ian E.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (05) : 1108 - 1114
  • [8] Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer
    Sara M. Tolaney
    Sally Tan
    Hao Guo
    William Barry
    Eliezer Van Allen
    Nikhil Wagle
    Jane Brock
    Katherine Larrabee
    Cloud Paweletz
    Elena Ivanova
    Pasi Janne
    Beth Overmoyer
    John J. Wright
    Geoffrey I. Shapiro
    Eric P. Winer
    Ian E. Krop
    Investigational New Drugs, 2015, 33 : 1108 - 1114
  • [9] Efficacy of RAD001/carboplatin in triple-negative metastatic breast cancer: A phase II study
    Singh, Jasmeet Chadha
    Volm, Matthew
    Novik, Yelena
    Speyer, James L.
    Adams, Sylvia
    Omene, Coral Oghenerukevwe
    Meyers, Marleen Iva
    Smith, Julia Anne
    Schneider, Robert
    Formenti, Silvia
    Goldberg, Judith D.
    Li, Xiaochun
    Davis, Samantha
    Beardslee, Brian
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [10] Peripheral blood biomarkers in Phase II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer
    Chumsri, Saranya
    Larson, Joseph J.
    Adams, Daniel L.
    Tenner, Kathleen S.
    Tang, Cha-Mei
    Weidner, Morgan T.
    Arnold, Amanda N.
    Haley, Dana L.
    Advani, Pooja
    Sideras, Kostandinos
    Moreno-aspitia, Alvaro
    Perez, Edith A.
    Knutson, Keith L.
    CANCER RESEARCH, 2023, 83 (07)
12345